Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
for T-cell Lymphoma
Sites in Aurora +9 more locations
Sponsor: SciTech Development, Inc.
Sex: All·Age: 18+
Code: NCT04234048·Phase 1·Recruiting·Listed Jan 2020